Mesoblast Limited is a world leader in the development of biologic products for the broad field of regenerative medicine. Mesoblast's patented Mesenchymal Precursor Cell (MPC) technology is being developed for an extensive range of major clinical diseases, including inflammatory and immunologic conditions of the joints and lungs, diabetes and kidney disease, orthopedic spine conditions, and cardiovascular disorders.
|
|
|
|
|
51-200 employees
View all Mesoblast employees
|
|
|
Medical Practices
|
|
|
Melbourne
|
|
|
2004
|
The decision makers in Mesoblast are Adrienne W, Alain Vertes, Michael Dimuro, etc. Click to Find Mesoblast decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.